Allostery Investments LP Tarsus Pharmaceuticals, Inc. Transaction History
Allostery Investments LP
- $95.7 Billion
- Q4 2024
A detailed history of Allostery Investments LP transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Allostery Investments LP holds 13,600 shares of TARS stock, worth $682,992. This represents 0.79% of its overall portfolio holdings.
Number of Shares
13,600Holding current value
$682,992% of portfolio
0.79%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
195Shares Held
42.9MCall Options Held
87KPut Options Held
21.2K-
Black Rock Inc. New York, NY3.27MShares$164 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$163 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$127 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$126 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$113 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.34B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...